CLINICAL_TRIALS
trial_result
· 2020-11-02
Clinical Trial Update: Long-Term Safety Evaluation of Dupilumab in Patients With Asthma (LIBERTY ASTHMA TRAVERSE) [Phase 3]
Summary
Long-term safety data from a Phase 3 trial evaluating dupilumab in asthma patients has been completed and results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sanofi | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2020-11-02